Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT03057834 · ClinicalTrials.gov registry record · NA

The Urinary Incontinence Treatment Study

A NA study of Urinary Incontinence and Sarcopenia, sponsored by Wake Forest University Health Sciences.

Completed
Registry status
NA
Development phase
70
Enrollment target
1
Study location

NCT03057834 is a NA study of Urinary Incontinence and Sarcopenia that has completed, run by Wake Forest University Health Sciences. The registered enrollment target is 70 participants, below the 261-participant average among 48 other Urinary Incontinence trials with a reported enrollment target (73% lower). The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT03057834, a NA study of Urinary Incontinence and Sarcopenia, has completed, sponsored by Wake Forest University Health Sciences.

COMPLETED
Registry status
NA
Development phase
70 participants
Enrollment target
1
Study location

Study Summary

Investigators plan a prospective cohort study with an adaptive design based on physical function status. The design will involve tracking the number of women recruited with physical function impairment and those without any functional impairment. Investigators aim to recruit similar numbers of women in each group. If investigators find unequal numbers, they will adapt recruit strategies based on a woman's functional status.

Interventions

  • BEHAVIORAL Pelvic floor muscle exercise

Study Locations (1)

North Carolina

  • Wake Forest Baptist Health - Winston-Salem

Trial Details

FieldValue
Enrollment Target 70 participants
Start Date 2017-03-01
Est. Completion 2020-01-29
Phase NA

Sponsor

Wake Forest University Health Sciences

1,140 total trials

What the Registry Record Tells You About NCT03057834

The ClinicalTrials.gov registry entry for NCT03057834 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 70 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 261-participant average among 48 other Urinary Incontinence trials with a reported enrollment target (73% lower). The listed sponsor is Wake Forest University Health Sciences, which has 1,140 total studies on file at ClinicalTrials.gov.

The record links to 2 conditions, with Urinary Incontinence appearing as the primary indexed condition, and to 1 intervention - of which Pelvic floor muscle exercise is the first listed.

NCT03057834 reports 1 study location spanning 1 distinct geographic area - top geographies include North Carolina.

Frequently Asked Questions

What is clinical trial NCT03057834 about?

NCT03057834 is a clinical study titled "The Urinary Incontinence Treatment Study". Investigators plan a prospective cohort study with an adaptive design based on physical function status. The design will involve tracking the number of women recruited with physical function impairment and those without any functional impairment. Investigators aim to recruit similar numbers of women...

What is the current status of trial NCT03057834?

This trial is currently completed. It is a NA study. The enrollment target is 70 participants. The study started on 2017-03-01. Estimated completion is 2020-01-29.

What conditions does trial NCT03057834 study?

This clinical trial studies the following conditions: Urinary Incontinence, Sarcopenia.

What interventions are being tested in trial NCT03057834?

The interventions under investigation include: Pelvic floor muscle exercise (BEHAVIORAL).

Who is sponsoring clinical trial NCT03057834?

This trial is sponsored by Wake Forest University Health Sciences, which has 1,140 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT03057834 being conducted?

This trial has 1 study location across North Carolina. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Urinary Incontinence

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.